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INTRODUCTION
Antimicrobial resistance is an important problem with serious public health impact. The spread of resistant microbial pathogens and resident microorganisms leads to therapeutic failures along with dramatic economic losses in livestock husbandry. On the other hand, the uncontrolled use of antimicrobial drugs could result in selection of multiresistant bacterial strains (DANMAP, 2009) .
Similarly to livestock species, the oral use of antimicrobial drugs in dogs exerts a selective pressure on commensal E. coli bacteria, which subsequently may cause the emergence of multiresistant strains. This could be realised by mutations in bacterial chromosome or genetic transfer from other representatives of intestinal microflora or transient bacteria. In this sense, resident E. coli are an interesting reservoir of various genetic factors conferring resistance to different groups of chemotherapeutics (Guardabassi et al., 2004) . Commensal multiresistant E. coli bacteria in the intestinal tract are an excellent indicator in studies on the spread of genes of antimicrobial resistance (Enne et al., 2008) .
The resistance to beta-lactam antibiotics, respectively third-and fourth-generation cephalosporins, cefotaxime, ceftazidime, ceftiofur etc. in pathogenic and resident E. coli producing extended-spectrum beta-lactamases (ESBL) is among the most extensively investigated mechanisms of resistance during the last years (Livermore, 2008) . Recently, the spread of ESBL-producing enterobacteria causing nosocomial and out-hospital infections has increased (Pitout, 2005) . Harada et al. (2014) reported a similar tendency in E. coli isolates from dogs as well. The spread of plasmid-mediated resistance to betalactams, expressed by AmpC enzymes and the resistance to beta-lactam inhibitors are problems discussed not only by human medicine, but also by livestock and pet medicine, in particular as E. coli isolates from dogs are concerned (Philippon et al., 2002; Carattoli et al., 2005) .
Although more rarely, data about resistance to antimicrobial drugs in canine E. coli isolates are reported in some European countries (SVARM, 2006; Costa et al., 2008) , and results are interpreted from ecological point of view including also risks related to antimicrobial drugs sales. That is why, in the Norwegian National Strategy Against Antibiotic Resistance 2015-2020 the government lays down steps for reducing resistance by 39% in pet bacterial isolates. Such a crucial step is not possible without analysis of objective information for antimicrobial drugs sales and the spread of resistance among bacteria (Anonymous, 2015) .
In Bulgaria, such an analysis could be extremely risky provided the lack of information on both aspects, e.g. the lack of objective information on sales volumes of antibiotics and for specific mechanisms of resistance in E. coli bacteria of public health significance.
This study aimed to investigate the prevalence of resistance in commensal canine E. coli isolates to different groups of antimicrobial drugs, with emphasis on some beta-lactam antibiotics. That is why the information for phenotypic expression of resistance to some beta-lactams was supplemented with genetic studies on the presence of resistance genes bla TЕМ , bla OXA-1 , bla CTX-M-1 .
MATERIALS AND METHODS
The study conducted between 2015 and 2017 and included 80 E. coli isolates from canine rectal swabs. Strains were isolated from patients of small animal clinics in Stara Zagora (n=36), Varna (n=20) and Burgas (n=24).
Isolation and identification of E. coli were performed by conventional microbiological methods and kits for identification of intestinal and non-fermenting bacteria (BBL). Results were interpreted by means of the semi-automated Crystal system (BBL).
The sensitivity of E. coli isolates to antimicrobial drugs was evaluated by the disk diffusion method and MIC determination (EUCAST, 2015) . The antibiotic disks used for evaluation of sensitivity of strains were loaded with: ampicillin (10 μg), amoxicillin/clavulanic acid (20/10 μg), cephalothin (30 μg), ceftazidime (10 μg), cefotaxime (5 μg), gentamicin (10 μg), tetracycline (30 μg), and ciprofloxacin (5 μg). They were produced by Emapol (Poland). ESBL production was determined with antibiotic disks loaded with beta-lactamase inhibitor clavulanic acid (20/10 μg) in combination with disks loaded with oxyimino-cephalosporins ceftazidime (30 μg) and cefotaxime (30 μg), Emapol (Poland).
MIC were determined by Liofilchem Test Strips (Italy). The strips displaying MIC scales were loaded with respective concentrations of cefotaxime (0.25-16 μg/mL) and ceftazidime (0.5-32 μg/mL).
For determination of inhibitory effect of clavulanic acid, strips loaded with ceftazidime+clavulanic acid (0.064-4 μg/mL) and cefotaxime+clavulanic acid (0.016-1 μg/mL) were used. The same tests were used for evaluation of sensitivity of E. coli strains, MIC of ampicillin, and amoxicillin/clavulanic acid. MIC of cephalothin was assayed by micro-broth dilution test and Muller-Hinton broth, Emapol (Poland). MIC methods were controlled with a reference strain Escherichia coli ATTC 25922.
The statistical processing of the data involved the determination of the confidence intervals with Graph Pad InStat 3.
DNA was extracted by means of DNeasy Blood Tissue kit (Qiagen, Germany). The following primers were used in bla TEM (850 bp) amplification protocol (Arlet et al., 1995) Amplification protocol of the bla OXA-1 gene used the following sequences of primers (Steward et al., 2001) Amplifications of bla CTX-M-1 were done in a STRATAGENE Mx3000P system. Ready microbial DNA assay kits (Qiagen, Germany) containing master mix, specific primer pairs and TaqMan probe loaded with FAM at the 5` end for the respective sequences of resistance genes, were used.
Apart the reaction components, kits contained also positive DNA control and internal amplification control. The standard protocol required the following amounts of components: 2× qPCR master mix -12.5 μL; qPCR primer pair and TaqMan probe -1 μL; extracted DNA -5 μL; DNA-free sterile water -6.5 μL. Total reaction volume was 25 μL.
The temperature regime of amplification included an initial activation step of 
RESULTS
The results on sensitivity of E. coli isolates from dogs to antimicrobial drugs demonstrated 47.5% resistance to ampicillin, 18.7% to amoxicillin/clavulanic acid and 6.2 % to cephalothin. The percentage of resistant E. coli strains to tetracycline was 26.2%, to ciprofloxacin -12.5%, and to gentamicin -10%. The resistance rates to cefotaxime and ceftazidime were the lowest -1.2% and 2.5% respectively (Table 1) .
MIC 90 values of ampicillin were 16 μg/mL, and for both amoxicillin/clavulanic acid and cephalothin -8 μg/mL. The main genotypic profile of resistance to tested beta-lactams involved the presence of bla TEM (Tables 2, 3; Fig. 1 ).
DISCUSSION
Investigations on resident E. coli bacteria place a particular emphasis on their resistance to fluorinated quinolones and novel generations of cephalosporins. Guardabassi et al. (2004) affirm that the selective pressure from the extensive use of antimicrobial drugs in pet medicine results mostly from the increasing application of aminopenicillins, as well as some secondand third-generation cephalosporins. The data on the spread of commensal E. coli isolates from dogs and cats, resistant to cephalosporins are still few compared to similar data in livestock species. In France, Haenni et al. (2014) reported a higher (18.5%) prevalence of resident canine E. coli strains with plasmids harbouring bla CTX-M-1 and bla CMY-2 genes, conferring production of extended-spectrum beta-lactamases, in comparison with other EC countries. In an earlier study from Portugal, Costa et al. (2008) reported 12% resistance to aminopenicillins but no resistance to ceftazidime in commensal canine and feline E. coli isolates. The authors detected the bla TEM gene in 70% of amoxicillin-resistant strains. Only two isolates from a single patient were resistant to cefotaxime and positive for the bla CTX-M-1 gene. Our results about antimicrobial resistance rates, respectively the genotype of commensal E. coli strains resistant to beta-lactams are similar to those published by Costa et al. (2008) , as we also observed high percent of amoxicillin-resistant strains possessing bla TEM gene (100%), but no bla CTX-M-1 in isolates resistant to cefotaxime and ceftazidime. Several years later in the Netherlands, Hordijk et al. (2013) found out that 45% of commensal E. coli isolates from dogs were resistant to cefotaxime and that the main genotype of this resistance pattern was associated with presence of the bla CTX-M-1 gene. In Brazil, Carvalho et al. (2016) discussed the broad spread of bla TEM and bla CTX-M-1 in resident E. coli strains detected in dogs and their owners. Ljungquist et al. (2016) established similar clones of resistant E. coli isolates from dogs and their owners, producing plasmid-mediated expended-spectrum beta-lactamases (bla AMC , bla TEM-1 , bla ). It should be kept in mind that integrons conferring multiresistance to antimicrobial drugs in enterobacteria have identical gene cassettes. In the different regions of the world, their sequences were identical (Ochoa et al., 2016) . It should be therefore affirmed that the animal population is a possible primary reservoir of integrons characterised with ubiquitous spread and possibility for transfer to species from the resident and pathogenic microflora.
